Precision Controlled Release of Biologics

Enable long-acting controlled release for peptides and other biologics by precision encapsulation. Control particle size, morphology, composition and more using IN-AIR-MICROFLUIDICS™ technology.

Discuss your project Explore our technology

A single platform delivering precision, performance, and scale

We turn complex formulation challenges into high-quality, scalable microparticle solutions.

Preserve biological activity

Formulation and process development focused on maintaining the integrity and activity of sensitive peptides and proteins

Engineer controlled release

Tuned particle size, morphology and internal structure to balance drug loading, initial burst and release duration.

Enable scalable production

Connect early formulation development with scalable production through parallel operation of our IN-AIR MICROFLUIDICS™ nozzles.

Particle morphology is key for controlled release

Release performance depends on more than just particle size. The distribution of your biologic within a particle and the structure surrounding it determine how it is protected and released.

With our IN-AIR MICROFLUIDICS™ technology we have control over particle size, composition and morphology. Using sold and porous matrix particles to core-shell structures, we address your formulation’s biologics loading, initial burst and release duration targets.

Precision engineering for scalable production

Our expertise in nozzle design and process engineering enables precise control over particle size, uniformity and internal structure. Parallel nozzle operation increases throughput while maintaining consistent conditions at each nozzle and uniform particle production.

We integrate early formulation development with the practical requirements of production at scale, including process stability, reproducibility and efficient use of valuable materials.

From formulation challenge to a defined development path

Whether you are exploring encapsulation for the first time or improving an existing formulation, we help identify a practical route forward.

Define the target

Discuss your molecule, intended delivery profile, material availability and key formulation requirements.

Develop and evaluate

Explore suitable materials and particle architectures, then evaluate loading, particle characteristics, release and retained activity against agreed targets.

Establish reproducibility

Translate the selected formulation into a robust production process, with consistent particle properties and a clear path to larger batches.

Controlled release for subcutaneous delivery

Developing long-acting biologic formulations requires a balance between initial burst, sustained release and retained biological activity.

Explore how particle architecture, polymer selection and formulation design can help address these challenges in subcutaneous injectable development.

Controlled Injectables

superior microencapsulation

One encapsulation platform. Endless possibilities.

IN-AIR MICROFLUIDICS™ offers microfluidic-level precision at industry-relevant scales. Our platform translates complex formulation challenges into microparticles with consistent quality and performance.

With proprietary encapsulation technology and strong formulation capabilities, we support products from early development to manufacturing, through microencapsulation services, co-development, or equipment integration.